Jennifer Stinson (L) and Daniel De Carvalho (supplied image, photo by Perry King)
Jennifer Stinson and Daniel De Carvalho receive Peter Gilgan Canada Gairdner Momentum Awards
Published: April 11, 2025
Jennifer Stinson, a senior scientist at the Hospital for Sick Children (SickKids) and professor in the Lawrence Bloomberg Faculty of Nursing, and Daniel De Carvalho, Allan Slaight Scientist at the Princess Margaret Cancer Centre, University Health Network (UHN) and associate professor of medical biophysics at the Temerty Faculty of Medicine, have been recognized with 2025 Peter Gilgan Canada Gairdner Momentum Awards.
The annual awards are given to Canadian mid-career researchers in recognition of exceptional scientific research contributions with continued potential for impact on human health.
Stinson is honoured for her contributions in the field of pediatric pain, specifically her use of digital interventions to improve chronic pain management in children. “Receiving the Peter Gilgan Canada Gairdner Momentum Award is an incredible honour,” said Stinson, who holds the Mary Jo Haddad Nursing Chair in Child Health. “It validates the important work we are doing in pediatric pain management and the need to continue advancing digital health interventions.”
De Carvalho was recognized for research that has transformed the understanding of how epigenetic changes drive cancer, and has led to novel approaches for early cancer detection and treatment. "Receiving the Gairdner Momentum Award is an incredible honour and a testament to the collaborative efforts of my team and colleagues," said De Carvalho, who holds a Canada Research Chair in Cancer Epigenetics and Epigenetic Therapy. "Our goal is to continue advancing cancer detection methods to improve patient outcomes and ultimately save lives."
Leah Cowen, U of T’s vice-president, research and innovation, and strategic initiatives, congratulated Stinson and De Carvalho on their respective honours. “Professor Stinson’s work in pediatric pain management and Professor De Carvalho’s contributions to cancer epigenetics are helping transform the lives of patients around the world,” said Cowen. “On behalf of U of T, I would like to extend my congratulations to these exceptional scholars on their worthy recognition by the Gairdner Foundation.”
